Literature DB >> 18957797

The metabolic syndrome as a concept of adipose tissue disease.

Eiji Oda1.   

Abstract

The metabolic syndrome is a constellation of interrelated metabolic risk factors that appear to directly promote the development of diabetes and cardiovascular disease. However, in 2005, the American Diabetes Association and the European Association for the Study of Diabetes jointly stated that no existing definition of the metabolic syndrome meets the criteria of a syndrome, and there have been endless debates on the pros and cons of using the concept of this syndrome. The controversy may stem from confusion between the syndrome and obesity. Obesity is an epidemic, essentially contagious disease caused by an environment of excess nutritional energy and reinforced by deeply rooted social norms. The epidemic of obesity should be prevented or controlled by social and political means, similar to the approaches now being taken to combat global warming. The diagnosis of metabolic syndrome is useless for this public purpose. The purpose of establishing criteria for diagnosing metabolic syndrome is to find individuals who are at increased risk of diabetes and cardiovascular disease and who require specific therapy including diet and exercise. The syndrome may be an adipose tissue disease different from obesity; in that case, it would be characterized by inflammation clinically detected through systemic inflammatory markers such as high-sensitivity C-reactive protein and insulin resistance reflecting histological changes in adipose tissue. However, many problems in defining the optimal diagnostic criteria remain unresolved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957797     DOI: 10.1291/hypres.31.1283

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  21 in total

1.  An exciting challenge for obesity research in Italy: the role of the Journal of Endocrinological Investigation.

Authors:  R Pasquali; R Vettor; S Cinti
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

Review 2.  Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis.

Authors:  C Merlotti; V Ceriani; A Morabito; A E Pontiroli
Journal:  Int J Obes (Lond)       Date:  2017-02-02       Impact factor: 5.095

Review 3.  Gastro-esophageal reflux disease and obesity, where is the link?

Authors:  Sara Emerenziani; Maria Paola Rescio; Michele Pier Luca Guarino; Michele Cicala
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

4.  Is there evidence of separate inflammatory or metabolic forms of preeclampsia?

Authors:  Sandra A Founds; Janet M Catov; Marcia J Gallaher; Gail F Harger; Nina Markovic; James M Roberts
Journal:  Hypertens Pregnancy       Date:  2010-05-12       Impact factor: 2.108

5.  Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients.

Authors:  Toru Miyoshi; Masayuki Doi; Satoshi Hirohata; Shigeshi Kamikawa; Shinichi Usui; Hiroko Ogawa; Kosuke Sakane; Reishi Izumi; Yoshifumi Ninomiya; Shozo Kusachi
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

6.  A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population.

Authors:  Eiji Oda; Ryu Kawai
Journal:  Environ Health Prev Med       Date:  2009-07-22       Impact factor: 3.674

7.  Visceral adiposity is not associated with inflammatory markers in trauma patients.

Authors:  Bryan Collier; Lesly Dossett; Jason Shipman; Matthew Day; George Lawson; Robert Sawyer; Addison May
Journal:  J Trauma       Date:  2010-01

Review 8.  Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.

Authors:  Biljana Musicki; Anthony J Bella; Trinity J Bivalacqua; Kelvin P Davies; Michael E DiSanto; Nestor F Gonzalez-Cadavid; Johanna L Hannan; Noel N Kim; Carol A Podlasek; Christopher J Wingard; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-12-08       Impact factor: 3.802

9.  Body mass index association with functional gastrointestinal disorders: differences between genders. Results from a study in a tertiary center.

Authors:  Michel Bouchoucha; Marinos Fysekidis; Chantal Julia; Gheorghe Airinei; Jean-Marc Catheline; Régis Cohen; Robert Benamouzig
Journal:  J Gastroenterol       Date:  2015-08-12       Impact factor: 7.527

Review 10.  Role of exercise on visceral adiposity after spinal cord injury: a cardiometabolic risk factor.

Authors:  Jacob A Goldsmith; Areej N Ennasr; Gary J Farkas; David R Gater; Ashraf S Gorgey
Journal:  Eur J Appl Physiol       Date:  2021-04-23       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.